Oxford has announced upcoming drug formulary changes effective 4/1/2012. Of particular importance, Lipitor will be upgraded to Tier 3 while atorvastatin (generic Lipitor) will be downgraded to Tier 2.

Attached is the full PDL list update per Oxford Health Plans. For more information, contact a New York health insurance broker.

Oxford Advantage PDL Benefit Updates – 7-1-12pdf